BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Pharmaceuticals, Inc. (NYSE Amex:INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its Senior Vice President of R&D and the Chair of its Scientific Advisory Board will present at the following major international vaccine conferences:
